The Journal of Thoracic and Cardiovascular Surgery
Volume 140, Issue 2 , Pages 356-363 , August 2010

Which patients should be operated on after induction chemotherapy for N2 non–small cell lung cancer? Analysis of a 7-year experience in 175 patients

Received 25 September 2009 ,Revised 2 January 2010 ,Accepted 8 February 2010.

References 

  1. Martini N, Kris MG, Flehinger BJ, Gralla RJ, Bains MS, Burt ME, et al. Preoperative chemotherapy for stage IIIA (N2) lung cancer: the Sloan–Kettering experience with 136 patients. Ann Thorac Surg. 1993;55:1365–1374
  2. Andre F, Grunenwald D, Pignon J, Dujon A, Pujol L, Brichon P, et al. Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications. J Clin Oncol. 2000;18:2981–2989
  3. Albain KS, Rusch VW, Crowley JJ, Rice TW, Turrisi AT, Weick JK, et al. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stage IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II Study 8805. J Clin Oncol. 1995;13:1880–1892
  4. Eberhardt W, Wilke H, Stamatis G, Stuschke M, Harstrick A, Menker H, et al. Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: mature results of a phase II trial. J Clin Oncol. 1998;16:622–634
  5. Lorent N, DeLeyn P, Lievens Y, Verbeken E, Nackaerts K, Dooms C, et al. Long-term survival of surgically staged IIIA-N2 non-small-cell lung cancer treated with surgical combined modality approach: analysis of a 7-year prospective experience. Ann Oncol. 2004;15:1645–1653
  6. Pass HI, Pogrebniak HV, Steinberg SM, Mulshine J, Minna J. Randomized trial of neoadjuvant therapy for lung cancer: interim analysis. Ann Thorac Surg. 1992;53:992–998
  7. Rosell R, Gómez-Codina J, Camps C, Maestre J, Padille J, Cantó A, et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N Engl J Med. 1994;330:153–158
  8. Roth JA, Fossella F, Komaki R, Ryan MB, Putnam JB, Lee JS, et al. A randomized trail comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. J Natl Cancer Inst. 1994;86:673–680
  9. Doddoli C, Barlesi F, Trousse D, Robitail S, Yena S, Astoul P, et al. One-hundred consecutive pneumonectomies after induction therapy for non–small cell lung cancer: an uncertain balance between risks and benefits. J Thorac Cardiovasc Surg. 2005;130:416–425
  10. Garrido P, Gonzalez-Larriba JL, Insa A, Provencio M, Torres A, Isla D, et al. Long-term survival associated with complete resection after induction chemotherapy in stage IIIA (N2) and IIIB (T4N0-1) non-small-cell lung cancer patients: the Spanish Lung Cancer Group Trial 9901. J Clin Oncol. 2007;25:4736–4742
  11. Alifano M, Boudaya MS, Salvi M, Collet JY, Dinu C, Camilleri-Broet S, et al. Pneumonectomy after chemotherapy: morbidity, mortality and long-term outcome. Ann Thorac Surg. 2008;85:1866–1873
  12. Albain KS, Swann RS, Rusch VR, Turrisi AT, Shepherd FA, Smith CJ, et al. Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial. Lancet. 2009;374:379–386
  13. Van Meerbeeck JP, Kramer GWPM, Van Schil PEY, Legrand C, Smit EF, Schramel F, et al. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer. J Natl Cancer Inst. 2007;99:442–450
  14. Robinson LA, Ruckdeschel JC, Wagner H, Stevens CW. Treatment of non–small cell lung cancer—stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007;132(3 Suppl):243S–265S
  15. Standards, options: recommandations. Traitement péri-opératoire des patients atteints d'un cancer bronchique non à petites cellules résécable d'emblée, opérables (rapport intégral). Rapport original 2000, mise à jour 2007. Available at: http://www.sor-cancer.fr
  16. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer. 1981;42:207–214
  17. Depierre A, Milleron B, Moro-Sibinot D, Chevret S, Quoix E, et al. Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II and IIIA non–small cell lung cancer. J Clin Oncol. 2001;20:247–253
  18. Nagai K, Tsuchiya R, Mori T, Tada H, Ichinose Y, Koike T, et al. A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non–small cell lung cancer (JCOG 9209). J Thorac Cardiovasc Surg. 2003;125:254–260
  19. Eberhardt WE, Albain KS, Pass H, Putnam JB, Gregor A, Assamura H. Induction treatment before surgery for non-small-cell lung cancer: IASLC consensus report. Lung Cancer. 2003;42:S9–S14
  20. Betticher DC, Hsu Schmitz SF, Tötsch M, Hansen E, Joss C, von Briel C, et al. Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial. J Clin Oncol. 2003;21:1752–1759
  21. Port JL, Korst RJ, Lee PC, Levin MA, Becker DE, Keresztes R, et al. Surgical resection for residual N2 disease after induction chemotherapy. Ann Thorac Surg. 2005;79:1686–1690
  22. Bueno R, Richards WG, Swanson SJ, Jaklitsch MT, Lukanich JM, Mentzen SJ, et al. Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival. Ann Thorac Surg. 2000;70:1826–1831
  23. De Waele M, Serra-Mitjans M, Hendriks J, Lauwers P, Belda-Sanchis J, Van Schil P, et al. Accuracy and survival of repeat mediastinoscopy after induction therapy for non-small-cell lung cancer in a combined series of 104 patients. Eur J Cardiothorac Surg. 2008;33:824–828
  24. Szlubowski A, Kuzdal J, Kolodziej M, Soja J, Pankowski J, Obrochta A, et al. Endobronchial ultrasound-guided needle aspiration in the non–small cell lung cancer staging. Eur J Cardiothorac Surg. 2009;35:332–336
  25. Adams K, Shah PL, Edmonds L, Lim E. Test performance of endobronchial ultrasound and transbronchial needle aspiration biopsy for mediastinal staging in patients with lung cancer: systematic review and meta-analysis. Thorax. 2009;64:757–762

 Disclosures: None.

PII: S0022-5223(10)00162-5

doi: 10.1016/j.jtcvs.2010.02.018

The Journal of Thoracic and Cardiovascular Surgery
Volume 140, Issue 2 , Pages 356-363 , August 2010

Article Tools

* Image Usage & Resolution